Literature DB >> 23648450

Galectin-9 in tumor biology: a jack of multiple trades.

Roy Heusschen1, Arjan W Griffioen, Victor L Thijssen.   

Abstract

Galectin family members have been shown to exert multiple roles in the context of tumor biology. Several recent findings support a similar multi-faceted role for galectin-9. Galectin-9 expression is frequently altered in cancer as compared to normal tissues. In addition, an increasing amount of evidence suggests that galectin-9 is involved in several aspects of tumor progression, including tumor cell adhesion and survival, immune escape and angiogenesis. Also, galectin-9 shows potential as a prognostic marker and a therapeutic target for several malignancies. In this review we summarize both the established and the emerging roles of galectin-9 in tumor biology and discuss the potential application of galectin-9 in anti-cancer therapy.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23648450     DOI: 10.1016/j.bbcan.2013.04.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  48 in total

Review 1.  Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.

Authors:  Alexander V Timoshenko
Journal:  Cell Mol Life Sci       Date:  2015-08-06       Impact factor: 9.261

2.  Effect of the use of Galectin-9 and blockade of TIM-3 receptor in the latent cellular reservoir of HIV-1.

Authors:  Marta Sanz; Nadia Madrid-Elena; Sergio Serrano-Villar; Alejandro Vallejo; Carolina Gutiérrez; Santiago Moreno
Journal:  J Virol       Date:  2020-12-23       Impact factor: 5.103

Review 3.  A review of the importance of immune responses in luminal B breast cancer.

Authors:  Delia J Nelson; Briony Clark; Kylie Munyard; Vincent Williams; David Groth; Jespal Gill; Henry Preston; Arlene Chan
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

4.  Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.

Authors:  Gang An; Chirag Acharya; Xiaoyan Feng; Kenneth Wen; Mike Zhong; Li Zhang; Nikhil C Munshi; Lugui Qiu; Yu-Tzu Tai; Kenneth C Anderson
Journal:  Blood       Date:  2016-07-14       Impact factor: 22.113

Review 5.  Galectin-9: From cell biology to complex disease dynamics.

Authors:  Sebastian John; Rashmi Mishra
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

6.  Structural Basis for Carbohydrate Recognition and Anti-inflammatory Modulation by Gastrointestinal Nematode Parasite Toxascaris leonina Galectin.

Authors:  Eun Young Hwang; Mi Suk Jeong; Sang Kyun Park; Sung Chul Ha; Hak Sun Yu; Se Bok Jang
Journal:  J Biol Chem       Date:  2016-10-14       Impact factor: 5.157

7.  Impact of Exogenous Galectin-9 on Human T Cells: CONTRIBUTION OF THE T CELL RECEPTOR COMPLEX TO ANTIGEN-INDEPENDENT ACTIVATION BUT NOT TO APOPTOSIS INDUCTION.

Authors:  Claire Lhuillier; Clément Barjon; Toshiro Niki; Aurore Gelin; Françoise Praz; Olivier Morales; Sylvie Souquere; Mitsuomi Hirashima; Ming Wei; Olivier Dellis; Pierre Busson
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

8.  Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.

Authors:  Hangcheng Fu; Yidong Liu; Le Xu; Weisi Liu; Qiang Fu; Haiou Liu; Weijuan Zhang; Jiejie Xu
Journal:  Tumour Biol       Date:  2015-02-26

9.  Self-assembled glycopeptide nanofibers as modulators of galectin-1 bioactivity.

Authors:  Antonietta Restuccia; Ye F Tian; Joel H Collier; Gregory A Hudalla
Journal:  Cell Mol Bioeng       Date:  2015-06-15       Impact factor: 2.321

10.  Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of beta interferon.

Authors:  Brian P McSharry; Simone K Forbes; John Z Cao; Selmir Avdic; Emily A Machala; David J Gottlieb; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.